SCP
CVS icon

Syntal Capital Partners’s CVS Health CVS Stock Holding History

Syntal Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,172
Closed -$487K – 98
2016
Q4 		$487K Buy
+6,172
New +$499K 0.45% 33
2015
Q3 		– Sell
-2,047
Closed -$214 – 140
2015
Q2 		$214 Buy
2,047
+13
+0.6% +$1.33K 0.21% 51
2015
Q1 		$209K Sell
2,034
-12
-0.6% -$1.21K 0.26% 53
2014
Q4 		$197K Buy
+2,046
New +$180K 0.12% 64

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Syntal Capital Partners's CVS Position: Q1 2017 in Review

Syntal Capital Partners sold out of CVS Health (CVS) in Q1 2017, closing a stake of 6,172 shares — an estimated $487K sold.

Syntal Capital Partners first reported a position in CVS in Q4 2014 and held it in 4 quarters. The position peaked at $487K in Q4 2016. 1,575 funds tracked by Wall St. Rank hold CVS as of Q1 2017.

  • Syntal Capital Partners reported no remaining CVS Health position as of Q1 2017 after selling out during the quarter.
  • Syntal Capital Partners sold 6,172 CVS Health shares in Q1 2017, an estimated $487K.
  • Syntal Capital Partners first reported a position in CVS Health in Q4 2014 and held it in 4 quarters.
  • Syntal Capital Partners's CVS Health position peaked at $487K in Q4 2016.
  • 1,575 funds tracked by Wall St. Rank held CVS Health as of Q1 2017.

Based on Syntal Capital Partners's 13F filing for Q1 2017, filed 2 May 2017.